2020
Sexual Health in Child and Adolescent Psychiatry: Multi-Site Implementation Through Synchronized Videoconferencing of an Educational Resource Using Standardized Patients
Drozdowicz L, Gordon E, Shapiro D, Jacobson S, Zalpuri I, Stewart C, Lewis AL, Robinson L, Myint MT, Daniolos P, Williamson ED, Pleak R, Martins A, Gleason MM, Galanter CA, Miller S, Stubbe D, Martin A. Sexual Health in Child and Adolescent Psychiatry: Multi-Site Implementation Through Synchronized Videoconferencing of an Educational Resource Using Standardized Patients. Frontiers In Psychiatry 2020, 11: 593101. PMID: 33329142, PMCID: PMC7716796, DOI: 10.3389/fpsyt.2020.593101.Peer-Reviewed Original ResearchSexual healthSexual functionStandardized patientsPatients' sexual functionMulti-site implementationAdolescent psychiatrySexual health curriculumMeasurable improvementUnderage patientsRoutine enquirySide effectsDisabled patientsClinical practicePatientsAmerican AcademyTraining programOutcomes pertinentEducational resourcesSynchronous videoconferencingSexual developmentExpert cliniciansCliniciansHealth curriculumPractices of childrenCAP training programs
2016
College students with autism spectrum disorders: A growing role for adult psychiatrists
van Schalkwyk GI, Beyer C, Martin A, Volkmar FR. College students with autism spectrum disorders: A growing role for adult psychiatrists. Journal Of American College Health 2016, 64: 575-579. PMID: 27347704, DOI: 10.1080/07448481.2016.1205072.Peer-Reviewed Original ResearchConceptsAutism spectrum disorderAttention-deficit/hyperactivity disorderSpectrum disorderCollege mental health practitionersMental health practitionersExecutive functionMental health needsInattentive symptomsHyperactivity disorderPsychiatric difficultiesCollege studentsClinical presentationPatient's clinical presentationMore side effectsFemale studentsLimited evidence baseApproach treatmentHealth practitionersStudentsDisordersEvidence baseCase reportHealth needsDiagnostic considerationsSide effects
2000
Research Units on Pediatric Psychopharmacology (Rupp) Autism Network Background and Rationale for an Initial Controlled Study of Risperidone
McDougle C, Scahill L, McCracken J, Aman M, Tierney E, Arnold L, Freeman B, Martin A, McGough J, Cronin P, Posey D, Riddle M, Ritz L, Swiezy N, Vitiello B, Volkmar F, Votolato N, Walson P. Research Units on Pediatric Psychopharmacology (Rupp) Autism Network Background and Rationale for an Initial Controlled Study of Risperidone. Child And Adolescent Psychiatric Clinics Of North America 2000, 9: 201-224. PMID: 10674197, DOI: 10.1016/s1056-4993(18)30142-1.Peer-Reviewed Original ResearchConceptsOpen-label trialDA neuronal systemsSafety of risperidoneStudy of RisperidonePlacebo-controlled studyUse of risperidoneExtrapyramidal side effectsTarget of pharmacotherapyTreatment of childrenImpaired social behaviorLong-term effectivenessPreclinical evidenceReceptor blockadeTypical antipsychoticsControlled StudyFirst drugPathophysiology of autismLower riskShort-term benefitsSide effectsRisperidonePotent effectsSymptoms of autismNeuronal systemsEnhanced efficacy
1999
Open-Label Quetiapine in the Treatment of Children and Adolescents with Autistic Disorder
Martin A, Koenig K, Scahill L, Bregman J. Open-Label Quetiapine in the Treatment of Children and Adolescents with Autistic Disorder. Journal Of Child And Adolescent Psychopharmacology 1999, 9: 99-107. PMID: 10461820, DOI: 10.1089/cap.1999.9.99.Peer-Reviewed Original ResearchConceptsClinical Global Impression ScaleTreatment of childrenSide effectsAutistic disorderOpen-label trialShort-term safetyWeeks of treatmentGlobal Impression ScaleGlobal improvement itemSignificant side effectsSerious side effectsDSM-IV criteriaFurther dose increasesLack of responseMean ageImpression ScalePossible seizuresMale subjectsWeight gainBehavioral activationFourth weekQuetiapine fumarateDose increaseClinical populationsWeeks